CADILAHC.NS - Cadila Healthcare Limited

NSE - NSE Real Time Price. Currency in INR
237.85
-1.05 (-0.44%)
At close: 3:29PM IST
Stock chart is not supported by your current browser
Previous Close238.90
Open0.00
Bid0.00 x 0
Ask0.00 x 0
Day's Range236.65 - 243.45
52 Week Range223.15 - 432.50
Volume1,638,045
Avg. Volume2,502,656
Market Cap242.545B
Beta (3Y Monthly)1.21
PE Ratio (TTM)13.17
EPS (TTM)18.06
Earnings DateN/A
Forward Dividend & Yield3.50 (1.52%)
Ex-Dividend Date2019-07-25
1y Target Est419.59
  • Reuters8 months ago

    Kraft Heinz to sell part of India business for about $630 million

    Indian pharmaceutical and consumer products company Zydus Wellness Ltd and its parent Cadila Healthcare Ltd will jointly buy the assets to expand their portfolio to also include brands such as talcum powder Nycil and clarified butter, Sampriti Ghee, the companies said in a statement on Wednesday. Complan, along with GlaxoSmithKline's health drinks brands Horlicks, was very popular until about a decade ago, when consumers used these products for supplemental nutrition along with milk.

  • Reuters8 months ago

    Kraft Heinz to sell part of India business for about $630 mln

    Kraft Heinz Co will sell part of its Indian business, including brands such as malt-based drink Complan and energy drink Glucon-D, for 45.95 billion rupees ($627.18 million), at a time when Indian consumers are demanding healthier, sugar-free alternatives. Indian pharmaceutical and consumer products company Zydus Wellness Ltd and its parent Cadila Healthcare Ltd will jointly buy the assets to expand their portfolio to also include brands such as talcum powder Nycil and clarified butter, Sampriti Ghee, the companies said in a statement on Wednesday. Complan, along with GlaxoSmithKline's health drinks brands Horlicks, was very popular until about a decade ago, when consumers used these products for supplemental nutrition along with milk.

  • Reuters8 months ago

    Kraft Heinz to sell part of Indian businesses to drugmaker Zydus - Bloomberg

    The deal with Ahmedabad-based Zydus, which is a unit of Cadila Healthcare Ltd, could be announced as early as this week, the report said, adding that Zydus has been discussing a value of about 46 billion rupees ($625 million) for the businesses. Earlier this month, the Indian media had reported that Zydus was close to a deal with Kraft Heinz for brands including Glucon-D and Nycil.

  • Simply Wall St.9 months ago

    A Holistic Look At Cadila Healthcare Limited (NSE:CADILAHC)

    Attractive stocks have exceptional fundamentals. In the case of Cadila Healthcare Limited (NSE:CADILAHC), there’s is a financially-robust , dividend-paying company with a a great history of performance. In the following Read More...

  • Should You Be Tempted To Buy Cadila Healthcare Limited (NSE:CADILAHC) At Its Current PE Ratio?
    Simply Wall St.10 months ago

    Should You Be Tempted To Buy Cadila Healthcare Limited (NSE:CADILAHC) At Its Current PE Ratio?

    This article is intended for those of you who are at the beginning of your investing journey and want to learn about the link between company’s fundamentals and stock marketRead More...